1359656-01-1

Basic information

• Product Name: IMidazo[1,2-a]pyridine-3-carboxylic acid, 6-broMo-, Methyl ester
• Synonyms: IMidazo[1,2-a]pyridine-3-carboxylic acid, 6-broMo-, Methyl ester;6-Bromo-imidazo[1,2-a]pyridine-3-carboxylic acid methyl ester
• CAS NO: 1359656-01-1
• Molecular Formula: C9H7BrN2O2
• Molecular Weight: 255.06808
• Mol File: 1359656-01-1.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: IMidazo[1,2-a]pyridine-3-carboxylic acid, 6-broMo-, Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: IMidazo[1,2-a]pyridine-3-carboxylic acid, 6-broMo-, Methyl ester(1359656-01-1)
• EPA Substance Registry System: IMidazo[1,2-a]pyridine-3-carboxylic acid, 6-broMo-, Methyl ester(1359656-01-1)

Safety Data

• Hazardous Substances Data: 1359656-01-1(Hazardous Substances Data)

Upstream product

• 138888-98-9 N’-(5-bromopyridin-2-yl)-N,N-dimethylformimidamide 
• 96-32-2 bromoacetic acid methyl ester 

Downstream Products

• 944896-42-8 6-bromoimidazo[1,2-a]pyridine-3-carboxylic acid 

Relevant articles and documents

2,3-DISUBSTITUTED PYRIDINE COMPOUNDS AS TGF-BETA INHIBITORS AND METHODS OF USE

The invention described herein comprises compounds of formula (IV) and a method of treating cancer comprising administering to a subject having cancer one of the compounds in conjunction with another therapeutic treatment of cancer. The compounds (IV) inhibit signaling by a member of the TGF-β superfamily such as Nodal or Activin.